Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents

Biomaterials

Volumn 56, Issue , 2015, Pages 140-153

  Liu, Jiangping ^a   Chen, Yu ^a   Li, Guanying ^a   Zhang, Pingyu ^a   Jin, Chengzhi ^a   Zeng, Leli ^a   Ji, Liangnian ^a   Chao, Hui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

3D multicellular spheroids; Mitochondria; Photodynamic therapy; Ruthenium(II) complex; Two photon

Indexed keywords

CELL DEATH; CHEMICAL ACTIVATION; LUMINESCENCE OF ORGANIC SOLIDS; MACHINERY; MITOCHONDRIA; OXYGEN; PHOTODYNAMIC THERAPY; PHOTONS; PHOTOSENSITIZERS; TWO PHOTON PROCESSES;

ANTI-CANCER AGENTS; ANTI-CANCER THERAPIES; MULTICELLULAR SPHEROID; RUTHENIUM COMPLEXES; RUTHENIUM POLYPYRIDYL COMPLEXES; TWO PHOTON; TWO PHOTON ABSORPTION; TWO-PHOTON ACTIVATION;

RUTHENIUM COMPOUNDS;

ANTINEOPLASTIC AGENT; CISPLATIN; RUTHENIUM COMPLEX; RUTHENIUM(II) POLYPYRIDYL COMPLEX 1; RUTHENIUM(II) POLYPYRIDYL COMPLEX 2; RUTHENIUM(II) POLYPYRIDYL COMPLEX 3; RUTHENIUM(II) POLYPYRIDYL COMPLEX 4; SINGLET OXYGEN; UNCLASSIFIED DRUG; COORDINATION COMPOUND; DRUG CARRIER; METHANOL; PHOTOSENSITIZING AGENT; RUTHENIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GEL CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED RADIATION; LIGHT ABSORPTION; LIMIT OF QUANTITATION; MASS SPECTROMETRY; MITOCHONDRION; MULTICELLULAR SPHEROID; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; QUANTUM YIELD; REACTION TIME; TARGET CELL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; FLUORESCENCE MICROSCOPY; HELA CELL LINE; IC50; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMOTHERAPY; PHOTON; PROCEDURES; RADIATION RESPONSE;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CISPLATIN; COORDINATION COMPLEXES; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; PHOTOCHEMOTHERAPY; PHOTONS; PHOTOSENSITIZING AGENTS; RUTHENIUM; SINGLET OXYGEN; SPHEROIDS, CELLULAR;

EID: 84928395653     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.04.002     Document Type: Article

References (73)

1. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
2. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995, 24:19-33.
3. Henze K., Martin W. Evolutionary biology: essence of mitochondria. Nature 2003, 426:127-128.
4. McBride H.M., Neuspiel M., Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol 2006, 16:R551-R560.
5. Green D.R. Apoptotic pathways: the roads to ruin. Cell 1998, 94:695-698.
6. Pervaiz S., Olivo M. Art and science of photodynamic therapy. Clin Exp Pharm Physiol 2006, 33:551-556.
7. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010, 9:447-464.
8. Robin A.J., Smith R.C.H., Murphy M.P. Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal 2011, 15:18.
9. Hoye A.T., Davoren J.E., Wipf P., Fink M.P., Kagan V.E. Targeting mitochondria. Acc Chem Res 2008, 41:87-97.
10. Dickinson B.C., Chang C.J. Atargetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. JAm Chem Soc 2008, 130:9638-9639.
11. Leung C.W.T., Hong Y., Chen S., Zhao E., Lam J.W.Y., Tang B.Z. Aphotostable AIE luminogen for specific mitochondrial imaging and tracking. JAm Chem Soc 2012, 135:62-65.
12. Armstrong J.S. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007, 151:10.
13. Hamilton G. Multicellular spheroids as an invitro tumor model. Cancer Lett 1998, 131:29-34.
14. Friedrich J., Seidel C., Ebner R., Kunz-Schughart L.A. Spheroid-based drug screen: considerations and practical approach. Nat Protoc 2009, 4:309-324.
15. Wang X., Zhen X., Wang J., Zhang J., Wu W., Jiang X. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. Biomaterials 2013, 34:4667-4679.
16. Gary-Bobo M., Mir Y., Rouxel C., Brevet D., Basile I., Maynadier M., et al. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors. Angew Chem Int Ed 2011, 123:11627-11631.
17. Zhao J., Wu W., Sun J., Guo S. Triplet photosensitizers: from molecular design to applications. Chem Soc Rev 2013, 42:5323-5351.
18. Li Y., Tan C.-P., Zhang W., He L., Ji L.-N., Mao Z.-W. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents. Biomaterials 2015, 39:95-104.
19. Ye R.R., Tan C.P., He L., Chen M.H., Ji L.N., Mao Z.W. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. Chem Commun 2014, 50:10945-10948.
20. 3IL excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model. JAm Chem Soc 2013, 135:17161-17175.
21. Zou Q., Fang Y., Zhao Y., Zhao H., Wang Y., Gu Y., et al. Synthesis and invitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy. JMed Chem 2013, 56:5288-5294.
22. Andrasik S.J., Belfield K.D., Bondar M.V., Hernandez F.E., Morales A.R., Przhonska O.V., et al. One-and two-photon singlet oxygen generation with new fluorene-based photosensitizers. ChemPhysChem 2007, 8:399-404.
23. Arnbjerg J., Jiménez-Banzo A., Paterson M.J., Nonell S., Borrell J.I., Christiansen O., et al. Two-photon absorption in tetraphenylporphycenes: are porphycenes better candidates than porphyrins for providing optimal optical properties for two-photon photodynamic therapy?. JAm Chem Soc 2007, 129:5188-5199.
24. Ke H., Wang H., Wong W.-K., Mak N.-K., Kwong D.W.J., Wong K.-L., et al. Responsive and mitochondria-specific ruthenium(II) complex for dual invitro applications: two-photon (near-infrared) induced imaging and regioselective cell killing. Chem Commun 2010, 46:6678-6680.
25. Collins H.A., Khurana M., Moriyama E.H., Mariampillai A., Dahlstedt E., Balaz M., et al. Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat Photon 2008, 2:420-424.
26. Allison R.R., Downie G.H., Cuenca R., Hu X.-H., Childs C.J.H., Sibata C.H. Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther 2004, 1:27-42.
27. Ishi-i T., Taguri Y., Kato S.-i., Shigeiwa M., Gorohmaru H., Maeda S., et al. Singlet oxygen generation by two-photon excitation of porphyrin derivatives having two-photon-absorbing benzothiadiazole chromophores. JMater Chem 2007, 17:3341-3346.
28. Sol V., Blais J.C., Carré V., Granet R., Guilloton M., Spiro M., et al. Synthesis, spectroscopy, and photocytotoxicity of glycosylated amino acid porphyrin derivatives as promising molecules for cancer phototherapy. JOrg Chem 1999, 64:4431-4444.
29. Koo C.K., So L.K.Y., Wong K.L., Ho Y.M., Lam Y.W., Lam M.H.W., et al. Atriphenylphosphonium-functionalised cyclometalated platinum(II) complex as a nucleolus-specific two-photon molecular dye. Chem Eur J 2010, 16:3942-3950.
30. Zhou W., Wang X., Hu M., Zhu C., Guo Z. Amitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through a multiple mechanism of action. Chem Sci 2014, 5:2761-2770.
31. Bergamo A., Sava G. Ruthenium complexes can target determinants of tumour malignancy. Dalton Trans 2007, 1267-1272.
32. Albani B.A., Peña B., Dunbar K.R., Turro C. New cyclometallated Ru (II) complex for potential application in photochemotherapy?. Photochem Photobiol Sci 2014, 13:272-280.
33. Albani B.A., Peña B., Leed N.A., de Paula N.A.B.G., Pavani C., Baptista M.S., et al. Marked improvement in photoinduced cell death by a new tris-heteroleptic complex with dual action: singlet oxygen sensitization and ligand dissociation. JAm Chem Soc 2014, 136:17095-17101.
34. Sgambellone M.A., David A., Garner R.N., Dunbar K.R., Turro C. Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru (II) Complex. JAm Chem Soc 2013, 135:11274-11282.
35. Higgins S.L.H., Brewer K.J. Designing red-light-activated multifunctional agents for the photodynamic therapy. Angew Chem Int Ed 2012, 51:11420-11422.
36. Pierroz V., Joshi T., Leonidova A., Mari C., Schur J., Ott I., et al. Molecular and cellular characterization of the biological effects of Ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid. JAm Chem Soc 2012, 134:20376-20387.
37. Mari C., Pierroz V., Ferrari S., Gasser G. Combination of Ru(II) complexes and light: new frontiers in cancer therapy. Chem Sci 2015, 10.1039/C4SC03759F.
38. Joshi T., Pierroz V., Mari C., Gemperle L., Ferrari S., Gasser G. Abis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection. Angew Chem 2014, 126:3004-3007.
39. Stephenson M., Reichardt C., Pinto M., Wächtler M., Sainuddin T., Shi G., et al. Ru(II) dyads derived from 2-(1-pyrenyl)-1H-imidazo[4,5-f][1,10]phenanthroline: versatile photosensitizers for photodynamic applications. JPhys Chem A 2014, 118:10507-10521.
40. Boca S.C., Four M., Bonne A., van der Sanden B., Astilean S., Baldeck P.L., et al. An ethylene-glycol decorated ruthenium(ii) complex for two-photon photodynamic therapy. Chem Commun 2009, 4590-4592.
41. Truillet C., Lux F., Moreau J., Four M., Sancey L., Chevreux S., et al. Bifunctional polypyridyl-Ru(ii) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy. Dalton Trans 2013, 42:12410-12420.
42. 2+. Sci China Ser B Chem 2009, 52:1504-1511.
43. Xu W., Zuo J., Wang L., Ji L., Chao H. Dinuclear ruthenium(II) polypyridyl complexes as single and two-photon luminescence cellular imaging probes. Chem Commun 2014, 50:2123-2125.
44. Sun D., Liu Y., Yu Q., Zhou Y., Zhang R., Chen X., et al. The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling. Biomaterials 2013, 34:171-180.
45. Puckett C.A., Barton J.K. Methods to explore cellular uptake of ruthenium complexes. JAm Chem Soc 2006, 129:46-47.
46. Cardinaels T., Ramaekers J., Nockemann P., Driesen K., Van Hecke K., Van Meervelt L., et al. Imidazo[4,5-f]-1,10-phenanthrolines: Versatile ligands for the design of metallomesogens. Chem Mater 2008, 20:1278-1291.
47. Jayabharathi J., ThanClam V., Venkatesh Perumal M., Srinivasan N. Synthesis, crystal structure, kamlet-taft and catalan solvatochromic analysis of novel imidazole derivatives. JFluoresc 2012, 22:409-417.
48. 2+). Solvent effects. JAm Chem Soc 1983, 105:5583-5590.
49. Crosby G.A., Demas J.N. Measurement of photoluminescence quantum yields. Review. JPhys Chem 1971, 75:991-1024.
50. Xu C., Webb W.W. Measurement of two-photon excitation cross sections of molecular fluorophores with data from 690 to 1050 nm. JOSA B 1996, 13:481-491.
51. 2 generation and photocleavage on DNA. JPhotochem Photobiol A Chem 2006, 177:286-294.
52. Li G.Y., Du K.J., Wang J.Q., Liang J.W., Kou J.F., Hou X.J., et al. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes. JInorg Biochem 2013, 119:43-53.
53. Abdel-Shafi A.A., Beer P.D., Mortimer R.J., Wilkinson F. Photosensitized generation of singlet oxygen from vinyl linked benzo-crown-ether-bipyridyl ruthenium(II) complexes. JPhys Chem A 1999, 104:192-202.
54. Fowley C., Nomikou N., McHale A.P., McCarron P.A., McCaughan B., Callan J.F. Water soluble quantum dots as hydrophilic carriers and two-photon excited energy donors in photodynamic therapy. JMater Chem 2012, 22:6456-6462.
55. Huang H., Zhang P., Yu B., Chen Y., Wang J., Ji L., et al. Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex. JMed Chem 2014, 57:8971-8983.
56. Steck E.A., Day A.R. Reactions of phenanthraquinone and retenequinone with aldehydes and ammonium acetate in acetic acid solution. JAm Chem Soc 1943, 65:452-456.
57. Makarov N.S., Drobizhev M., Rebane A. Two-photon absorption standards in the 550-1600 nm excitation wavelength range. Opt Express 2008, 16:4029-4047.
58. Velusamy M., Shen J.Y., Lin J.T., Lin Y.C., Hsieh C.C., Lai C.H., et al. Anew series of quadrupolar type two-photon absorption chromophores bearing 11,12-dibutoxydibenzo[a,c]-phenazine bridged amines; their applications in two-photon fluorescence imaging and two-photon photodynamic therapy. Adv Funct Mater 2009, 19:2388-2397.
59. Botchway S.W., Charnley M., Haycock J.W., Parker A.W., Rochester D.L., Weinstein J.A., et al. Time-resolved and two-photon emission imaging microscopy of live cells with inert platinum complexes. Proc Natl Acad Sci U S A 2008, 105:16071-16076.
60. Koo C.K., Wong K.L., Man C.W.Y., Lam Y.W., So L.K.Y., Tam H.L., et al. Abioaccumulative cyclometalated platinum(II) complex with two-photon-induced emission for live cell imaging. Inorg Chem 2009, 48:872-878.
61. Lo K.K.W., Louie M.W., Zhang K.Y. Design of luminescent iridium(III) and rhenium(I) polypyridine complexes as invitro and invivo ion, molecular and biological probes. Coord Chem Rev 2010, 254:2603-2622.
62. Young R.H., Wehrly K., Martin R.L. Solvent effects in dye-sensitized photooxidation reactions. JAm Chem Soc 1971, 93:5774-5779.
63. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010, 110:2795-2838.
64. Cho S., You Y., Nam W. Lysosome-specific one-photon fluorescence staining and two-photon singlet oxygen generation by molecular dyad. RSC Adv 2014, 4:16913-16916.
65. Yang Y., Guo Q., Chen H., Zhou Z., Guo Z., Shen Z. Thienopyrrole-expanded BODIPY as a potential NIR photosensitizer for photodynamic therapy. Chem Commun 2013, 49:3940-3942.
66. Adam W., Kazakov D.V., Kazakov V.P. Singlet-oxygen chemiluminescence in peroxide reactions. Chem Rev 2005, 105:3371-3387.
67. Frederiksen P.K., Jørgensen M., Ogilby P.R. Two-photon photosensitized production of singlet oxygen. JAm Chem Soc 2001, 123:1215-1221.
68. Gomes A., Fernandes E., Lima J.L. Fluorescence probes used for detection of reactive oxygen species. JBiochem Biophys Methods 2005, 65:45-80.
69. Majumdar P., Yuan X., Li S., Le Guennic B., Ma J., Zhang C., et al. Cyclometalated Ir(III) complexes with styryl-BODIPY ligands showing near IR absorption/emission: preparation, study of photophysical properties and application as photodynamic/luminescence imaging materials. JMater Chem B 2014, 2:2838-2854.
70. Li S.P.Y., Lau C.T.S., Louie M.W., Lam Y.W., Cheng S.H., Lo K.K.W. Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity. Biomaterials 2013, 34:7519-7532.
71. Pluen A., Boucher Y., Ramanujan S., McKee T.D., Gohongi T., di Tomaso E., et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci U S A 2001, 98:4628-4633.
72. Netti P.A., Berk D.A., Swartz M.A., Grodzinsky A.J., Jain R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000, 60:8.
73. Goodman T.T., Ng C.P., Pun S.H. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjug Chem 2008, 19:1951-1959.